Vaccines against Covid-19 that were developed by US drug makers Pfizer and Moderna may not be as effective against the 'Delta' variant compared to as they were against the original strain of the virus, suggests a new study.
Researchers from the Mayo Clinic in Minnesota, US, found that the Pfizer-BioNTech vaccine was only 42 per cent effective against infection in July, while the Moderna vaccine was only 76 per cent effective, the Daily Mail reported.
"Comparing rates of infection between matched individuals fully vaccinated with mRNA-1273 (Moderna Covid vaccine) versus BNT162b2 (Pfizer Covid vaccine) across Mayo Clinic Health System sites in multiple states (Minnesota, Wisconsin, Arizona, Florida, and Iowa), mRNA-1273 conferred a two-fold risk reduction against breakthrough infection compared to BNT162b2," the researchers wrote in the study, not yet peer reviewed, and published on pre-printer server medRxiv.org.
For the study, the team gathered data on more than 25,000 Minnesotans from January to July.
From January to June, the vaccines as claimed remained effective around 90 per cent, but began dipping in June and largely dropped in July as the variant took hold in the US.
The change in vaccine effectiveness corresponds with a massive surge in the prevalence of the Delta variant in Minnesota, growing from 0.7 per cent prevalence in May to more than 70 per cent in July, the study showed.
Meanwhile, the 'Alpha' variant, the previous dominant strain in the US, decreased in prevalence from 85 per cent to 13 per cent over the same time period.
The US is currently seeing a spike in infections and death due to the Delta variant. As of Thursday morning, the overall caseload and death toll in the US stood at 36,185,761 and 618,454, respectively, according to Johns Hopkins University. It is projected to increase in the coming weeks.
However, the vaccines are still effective in preventing hospitalisations and severe cases from the virus, with both having a hospitalisation rate of under 25 per cent, the researchers said.
Last month, Pfizer published data which showed that its vaccine's efficacy drops to 86 per cent after six months.
But booster shots, expected to be rolled out soon, can help enhance immunity to the virus and protect against more resistant variants.
Govt slashes prices of 41 medicines
Antacids, multivitamins, and antibiotics are among the medicines that will become cheaper, according to a notification issued by the Department of Pharmaceuticals and National Pharmaceutical Pricing Authority (NPPA).
At least 1 in 5 new mothers experiences postpartum depression: Doctors
While parenthood comes as a blessing for many, for more than 20 per cent of mothers, the new chapter of life creates stress, anxiety and postpartum depression, which can turn fatal for both the mother and child, without adequate support, said doctors on Mother’s Day on Sunday.
New immunotherapy to fight cancer, keep healthy cells safe
A team of US researchers has developed a new immunotherapy technique that uses cytokine proteins as a potential treatment, effectively targeting tumours without causing harm to healthy cells.
Why excess sugar, oil are as dangerous for liver as alcohol
While alcohol is known to be bad for liver health, consuming foods rich in sugar and oil may be equally dangerous for the organ as well as for overall health, said doctors on Thursday, ahead of World Liver Day.
Lungs of young adults more susceptible to SARS-CoV-2 virus: Study
While older age has been associated with an increased risk of SARS-CoV-2, the virus responsible for Covid-19, a new study has revealed that the lungs of young adults are more susceptible to the virus.
Congress in Tripura blocks rail stations to protest police fired-killing of 5 farmers in MP
The firing on Tuesday came during raucous protests to demand better crop prices in the drought-ravaged region that saw one farmer suicide every five hours in the past two years.
DMs, SPs of violence-hit MP districts transferred
The farmers agitation entered its eighth day on Thursday. The peasants have been on strike since June 1, demanding loan waiver and fair price for their produce.
Indian American selected among 12 NASA astronaut candidates
He continued on to earn a master's degree in aeronautics and astronautics from Massachusetts Institute of Technology and graduated from the US Naval Test Pilot School.